Multiple Assemblies exist for SMTL entry 5aaw
Structure of a redesigned cross-reactive antibody to dengue virus with increased in vivo potency; X-RAY DIFFRACTION 3.27 Å

SMTL ID
5aaw.1
Ligands
-
Polypeptides
SCFV513; DENGUE SEROTYPE 4 ENVELOPE PROTEIN DOMAIN 3
Oligo-state
hetero-oligomer
SMTL ID
5aaw.2
Ligands
-
Polypeptides
SCFV513; DENGUE SEROTYPE 4 ENVELOPE PROTEIN DOMAIN 3
Oligo-state
hetero-oligomer
SMTL ID
5aaw.3
Ligands
-
Polypeptides
SCFV513; DENGUE SEROTYPE 4 ENVELOPE PROTEIN DOMAIN 3
Oligo-state
hetero-oligomer
SMTL ID
5aaw.4
Ligands
-
Polypeptides
SCFV513; DENGUE SEROTYPE 4 ENVELOPE PROTEIN DOMAIN 3
Oligo-state
hetero-oligomer
SMTL ID
5aaw.5
Ligands
-
Polypeptides
SCFV513; DENGUE SEROTYPE 4 ENVELOPE PROTEIN DOMAIN 3
Oligo-state
hetero-oligomer
SMTL ID
5aaw.6
Ligands
-
Polypeptides
SCFV513; DENGUE SEROTYPE 4 ENVELOPE PROTEIN DOMAIN 3
Oligo-state
hetero-oligomer